Tom McHugh | Chief Financial Officer |
Greg Divis | Chief Executive Officer |
Jennifer Gudeman | Vice President of Medical and Clinical Affairs |
Richard Kim | Chief Commercial Officer |
Paul Matteis | Stifel |
David Amsellem | Piper Sandler |
Francois Brisebois | Oppenheimer |
Madhu Yennawar | SVB Leerink |
David Sherman | Lifesci Capital |
Robin Garner | Craig-Hallum |
Oren Livnat | HC Wainwright |
Greetings and welcome to the Avadel Pharmaceuticals First Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Tom McHugh, Chief Financial Officer.